Mirus Bio
Related Stories
Madison-based life science company Mirus Bio to be acquired for $600 million
Mirus Bio, a manufacturer of transfection regents used in gene therapies, has entered into an agreement to be acquired.
Up-to-the-minute business news, thoughtful analysis and valuable strategic insights for Milwaukee and Southeastern Wisconsin business leaders.
Copyright © 2024 BizTimes - Milwaukee Business News. All Rights Reserved.
Holiday flash sale!
Limited time offer. New subscribers only.
Subscribe to BizTimes Milwaukee and save 40%
Holiday flash sale! Subscribe to BizTimes and save 40%!
Limited time offer. New subscribers only.